Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells - PubMed (original) (raw)
. 1991 Jan 1;51(1):144-9.
Affiliations
- PMID: 1988079
Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells
E Barker et al. Cancer Res. 1991.
Abstract
An anti-GD2 ganglioside human/mouse chimeric monoclonal antibody, ch14.18, like its murine counterpart, 14.G2a, was shown to bind to human neuroblastoma cells. This chimeric antibody proved to be more effective than 14.G2a in mediating the lysis of neuroblastoma cells with human effector cells, such as granulocytes and natural killer cells within the peripheral blood mononuclear cell population. A comparison of these two effector cell populations isolated from the same donor revealed granulocytes to be more effective than peripheral blood mononuclear cells in lysing neuroblastoma cells, which were coated with monoclonal antibody ch14.18. Addition of recombinant human granulocyte-macrophage colony-stimulatory factor increased ch14.18-mediated lysis of neuroblastoma cells by granulocytes but not by peripheral blood mononuclear cells. In fact, granulocytes were effective in mediating lysis of neuroblastoma cells coated with ch14.18 irrespective of whether they were obtained from normal adults or from neuroblastoma patients.
Similar articles
- Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).
Hank JA, Surfus JE, Gan J, Jaeger P, Gillies SD, Reisfeld RA, Sondel PM. Hank JA, et al. Clin Cancer Res. 1996 Dec;2(12):1951-9. Clin Cancer Res. 1996. PMID: 9816154 - Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.
Zeng Y, Fest S, Kunert R, Katinger H, Pistoia V, Michon J, Lewis G, Ladenstein R, Lode HN. Zeng Y, et al. Mol Immunol. 2005 Jul;42(11):1311-9. doi: 10.1016/j.molimm.2004.12.018. Epub 2005 Apr 7. Mol Immunol. 2005. PMID: 15950727 - Combination therapy with interleukin-2 and antitumor monoclonal antibodies.
Sondel PM, Hank JA. Sondel PM, et al. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S121-7. Cancer J Sci Am. 1997. PMID: 9457407 Review. - Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.
Parsons K, Bernhardt B, Strickland B. Parsons K, et al. Ann Pharmacother. 2013 Feb;47(2):210-8. doi: 10.1345/aph.1R353. Epub 2013 Feb 5. Ann Pharmacother. 2013. PMID: 23386066 Review.
Cited by
- Targeting the myeloid microenvironment in neuroblastoma.
Stip MC, Teeuwen L, Dierselhuis MP, Leusen JHW, Krijgsman D. Stip MC, et al. J Exp Clin Cancer Res. 2023 Dec 13;42(1):337. doi: 10.1186/s13046-023-02913-9. J Exp Clin Cancer Res. 2023. PMID: 38087370 Free PMC article. Review. - IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models.
Stip MC, Evers M, Nederend M, Chan C, Reiding KR, Damen MJ, Heck AJR, Koustoulidou S, Ramakers R, Krijger GC, de Roos R, Souteyrand E, Cornel AM, Dierselhuis MP, Jansen M, de Boer M, Valerius T, van Tetering G, Leusen JHW, Meyer-Wentrup F. Stip MC, et al. J Immunother Cancer. 2023 Jul;11(7):e006948. doi: 10.1136/jitc-2023-006948. J Immunother Cancer. 2023. PMID: 37479484 Free PMC article. - Humanized MISTRG as a preclinical in vivo model to study human neutrophil-mediated immune processes.
Martinez-Sanz P, Laurent ARG, Slot E, Hoogenboezem M, Bąbała N, van Bruggen R, Rongvaux A, Flavell RA, Tytgat GAM, Franke K, Matlung HL, Kuijpers TW, Amsen D, Karrich JJ. Martinez-Sanz P, et al. Front Immunol. 2023 Mar 8;14:1105103. doi: 10.3389/fimmu.2023.1105103. eCollection 2023. Front Immunol. 2023. PMID: 36969261 Free PMC article. - Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.
Wang W, Spurgeon ME, Pope A, McGregor S, Ward-Shaw E, Gronski E, Lambert PF. Wang W, et al. Proc Natl Acad Sci U S A. 2023 Mar 21;120(12):e2214225120. doi: 10.1073/pnas.2214225120. Epub 2023 Mar 14. Proc Natl Acad Sci U S A. 2023. PMID: 36917668 Free PMC article. - Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions.
Estevez-Ordonez D, Gary SE, Atchley TJ, Maleknia PD, George JA, Laskay NMB, Gross EG, Devulapalli RK, Johnston JM. Estevez-Ordonez D, et al. Pediatr Neurosurg. 2023;58(5):313-336. doi: 10.1159/000528792. Epub 2022 Dec 22. Pediatr Neurosurg. 2023. PMID: 36549282 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical